Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Vertex

Vertex (NASDAQ:VERX) reported its Q1 earnings results on Tuesday, May 10, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga

Dow Jones Sells Off After Jobs Report As Treasury Yields Hit New High

The Dow Jones Industrial Average dropped Friday morning after the key April jobs report. The 10-year Treasury yield hit a new high.

Investors Business Daily

Stocks That Lift This JPMorgan Fund In Down Market

Most mutual funds have losses this year amid the market's sell-off. But JPMorgan Large Cap Value Fund is in positive territory. Here's why.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Dow Jones Futures Fall After Stocks Plunge, Treasury Yields Soar In Delayed Fed Reaction

Treasury yields surged in a delayed reaction to the Fed meeting. Stocks dived, wiping out Wednesday's market rally.

Investors Business Daily

Why Vertex Pharma's Pipeline Has Never Been More Important

Vertex will need to lean on its pipeline to prop VRTX stock, an analyst said Thursday after the company delivered a mixed report.

Investors Business Daily

Dow Jones Gains; These Warren Buffett Stocks Charge; Pharma Leader Hit By This Surprise Move

The Dow Jones fell as the 10-year treasury yield spiked., A couple of Warren Buffett stocks popped higher. Intel led the blue chips.

Investors Business Daily

Tesla, Lilly, Microsoft Fight Sell-Off As Indexes Search For Bottom

With the market searching for a bottom, Tesla, Microsoft, Eli Lilly and other leading stocks try to recharge as May kicks off.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Why Vertex Pharmaceuticals Shares Are Falling

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) shares are trading lower by 3.42% to $263.88 during Monday’s pre-market session after the company announced VX-880 Phase 1/2 has been placed on clinical hold by the FDA due to “a determination that there is insufficient information to support do

Benzinga

This Obscure Stock Has Outperformed Tech And EV Giants

Vertex Energy Inc (NASDAQ: VTNR) has an average trading volume of over 2 million, so it is no slouch of a stock in terms of interest.

Benzinga

Will New Buys By The Best Mutual Funds Prop Up These Big-Name, But Pressured Stocks?

Making the latest list of new buys by the best mutual funds, Apple and GOOGL face headwinds, while Vertex and Lilly weather the storm.

Investors Business Daily

Vertex Has a Pain Pill That May Replace Opioids

Vertex is one step closer to getting its new pain pill approved, which could substitute for opioids that are highly addictive.

The Street

Dow Jones Falls As Biden Taps Emergency Oil, Inflation Gauge Hits 39-Year High; Pharma Leader Pops

The Dow Jones fell as President Joe Biden tapped the nation's emergency oil reserves. The Fed's favorite inflation gauge spiked.

Investors Business Daily

Dow Jones Continues To Pull Back After Recent Rally; Investors Await Biden's Release Of Oil Reserves

Elsewhere, Paychex rose over 1% and moved above a proper buy point.

Investors Business Daily

Vertex Touts Positive Data From Mid-Stage Study Of Its Non-Opioid Pain Drug

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) released positive results from two Phase 2 post-operative trials for its non-opioid program, VX-548. One trial looked at patients who had just received a bunionectomy (Correcting the deformity of toes & foot), the other in patients who received abdominoplasty (tummy tuck). Vertex said that within 48 hours of surgery,…

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Stock Market Falls As Biden To Release Oil Reserves; Key Inflation Rate Rises

The stock market traded lower as President Biden prepared to release oil reserves, sending oil prices lower.

Investors Business Daily

Vertex Continues Its Meteoric Run After Its Opioid Alternative Scores In A Key Test

Vertex announced promising test results for its opioid alternative on Thursday, sending VRTX stock deeper into breakout territory.

Newcastle Herald

Well played: Cause for celebration as cystic fibrosis drug added to the PBS

Without PBS subsidy, around 1,900 Australians would be up for more than $250,000 a year to access the CF drug.

Investors Business Daily

IBD Screen Of The Day: 3 Stocks Near Buy Points With Rising Profit Estimates

Vertex Pharmaceuticals has been outperforming and ranks second in the biotech industry group.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Dow Jones Futures: Nasdaq Breaks Lower; China Covid Shutdowns Are New X Factor

China's Covid shutdowns slammed tech stocks and oil prices. The Nasdaq broke below its Feb. 24 lows, but the S&P 500 hasn't yet.

Benzinga

What's Going On With Vertex Energy Shares Today?

Vertex Energy Inc (NASDAQ: VTNR) is trading higher on above-average volume Thursday as oil prices gain following the collapse of Russia-Ukraine ceasefire talks.

The Street

Vertex Pharma Has a Cystic Fibrosis Drug That Rivals Envy

A gene therapy by Vertex Pharma has turned out to be a money spinner for the company.

The Street

Biotech Vertex Pharma Has a Blockbuster Drug That Rivals Envy

A gene therapy by Vertex Pharma has turned out to be a money spinner for the company.

Benzinga

Vertex Clocks 12% Revenue Growth In Q4 Backed By ARR, NRR Momentum; Issues FY22 Guidance Above Consensus

Vertex Inc (NASDAQ:VERX) reported fourth-quarter FY21 revenue growth of 12.2% year-on-year to $111.7 million, beating the consensus of $109.2 million. Software subscription revenues rose 11.1% Y/Y to $93.3 million, and Cloud revenues increased 38.9% Y/Y to $34.7 million. Drivers: Annual Recurring Revenue rose 17% Y/Y to $370.2 million. The Average Annual Revenue per customer…

Benzinga

Vertex: Q4 Earnings Insights

Vertex (NASDAQ:VERX) reported its Q4 earnings results on Wednesday, March 9, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga

Vertex Energy Stock Skyrockets After Q4 Results; Expects To Close Mobile Refinery Deal As Planned

Vertex Energy Inc (NASDAQ:VTNR) reported fourth-quarter revenue growth of 82.5% year-over-year to $31.79 million, beating the consensus of $29.37 million. Q4 Adjusted net income recovered to $4.64 million from a loss of $(2.74) million in 4Q20. The gross margin declined by 130 bps to 1%. The company reported an operating loss of $(7.46)…

1 … 7 8 9 10

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.